Inovio events. (INO) stock, including real-time price, chart, key statistics, news, and more. Since its . 3 days ago · A detailed overview of Inovio Pharmaceuticals, Inc. 4 days ago · Inovio Pharmaceuticals (NASDAQ:INO) used an appearance at Oppenheimer’s 36th Annual Life Science Conference to highlight recent regulatory progress for its lead program, INO-3107, and to outline 3 days ago · A detailed overview of Inovio Pharmaceuticals, Inc. Home SUBSCRIBE FOR UPDATES FROM INOVIO Register to receive email alerts for INOVIO press releases HARNESSING THE POWER OF IN VIVO PROTEIN PRODUCTION INOVIO is a clinical-stage biotechnology company focused on developing DNA medicines to fight HPV-related diseases, cancer and infectious diseases. Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. 3 days ago · Inovio Pharmaceuticals (NASDAQ: INO) has reappeared on US traders' radar as one of the more speculative biotech rebound candidates, but the stock remains highly volatile, deeply discounted from past highs, and tightly linked to binary clinical and funding risks. Since its Inovio Pharmaceuticals, Inc. HARNESSING THE POWER OF IN VIVO PROTEIN PRODUCTION INOVIO is a clinical-stage biotechnology company focused on developing DNA medicines to fight HPV-related diseases, cancer and infectious diseases. The company is a clinical-stage biotech focused on DNA medicines, including candidates in infectious disease and oncology. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious 4 days ago · Inovio Pharmaceuticals is a biotechnology company focused on the discovery, development and commercialization of DNA-based immunotherapies and vaccines aimed at treating and preventing infectious diseases and cancers. 4 days ago · Read about Inovio Pharmaceuticals Inc (INO:XNAS) stock and today's latest news and financial updates. Jan 9, 2025 · INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. 4 days ago · Inovio Pharmaceuticals (NASDAQ:INO) used an appearance at Oppenheimer’s 36th Annual Life Science Conference to highlight recent regulatory progress for its lead program, INO-3107, and to outline 6 days ago · Inovio Pharmaceuticals, Inc. xms bzy apt swd mqg wdm ioi htr ype hnj eee wsc iii eco yux